(Q48722093)

15 February 2018

title

Do alprazolam-induced changes in saccadic eye movement and psychomotor function follow the same time course? (English)

1 reference

15 February 2018

1 reference

Kroboth PD

1

1 reference

15 February 2018

Folan MM

2

1 reference

15 February 2018

Bauer KS

3

1 reference

15 February 2018

Tullock W

4

1 reference

15 February 2018

Wright CE

5

1 reference

15 February 2018

Sweeney JA

6

1 reference

15 February 2018

publication date

1 April 1998

1 reference

15 February 2018

The Journal of Clinical Pharmacology

published in

1 reference

15 February 2018

volume

38

1 reference

15 February 2018

issue

4

1 reference

15 February 2018

page(s)

337-346

1 reference

15 February 2018

Orally administered progesterone enhances sensitivity to triazolam in postmenopausal women.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04433.X

Simultaneous modeling of the pharmacokinetic and pharmacodynamic properties of benzodiazepines. II. Triazolam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04433.X

Pharmacokinetics and pharmacodynamics of triazolam after two intermittent doses in obese and normal-weight men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04433.X

Commentary. Effect of benzodiazepines upon saccadic eye movements in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04433.X

Saccadic eye movement analysis as a measure of drug effects on human psychomotor performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04433.X

The relationship between peak velocity of saccadic eye movements and serum benzodiazepine concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04433.X

Benzodiazepine pharmacodynamics: utility of eye movement measures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04433.X

Rate of entrance of benzodiazepines into the brain determined by eye movement recording

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04433.X

Pharmacology of saccadic eye movements in man. 1. Effects of the benzodiazepine receptor ligands midazolam and flumazenil

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04433.X

Reduced benzodiazepine sensitivity in panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04433.X

Measurement of acute tolerance to alcohol in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04433.X

Alprazolam in the elderly: pharmacokinetics and pharmacodynamics during multiple dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04433.X

Pharmacokinetic-pharmacodynamic modeling of the central nervous system effects of midazolam and its main metabolite alpha-hydroxymidazolam in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04433.X

Evaluation of saccadic eye movements as an objective test of recovery from anaesthesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04433.X

Effects on eye movements of a GABA agonist and antagonist injected into monkey superior colliculus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04433.X

Optokinetic and vestibulo-ocular reflex adjustment by GABA antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04433.X

Thyrotropin-releasing hormone selectively reverses lorazepam-induced sedation but not slowing of saccadic eye movements

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04433.X

Effects of diphenhydramine on human eye movements.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1998.TB04433.X

10.1002/J.1552-4604.1998.TB04433.X

21 January 2018

Identifiers

DOI

1 reference

15 February 2018

PubMed ID

9590461

1 reference

15 February 2018